Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
FDA unveils new plan for genome therapy editing
The guidance allows sponsors to build on data generated from previous R&D programmes.
Read more
Women’s health market booms – but gaps persist
As International Women’s Day approaches, data on the global women’s health market paints a mixed picture.
AI could unlock new cystic fibrosis protein target
The hunt for new cystic fibrosis therapies is going digital, as the Cystic Fibrosis Foundation taps Antiverse for AI antibody design.
Month in pharma news, explained – February 2026
In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on February 2026.
Novo Nordisk invests €432m in Irish tablet plant
Novo Nordisk is refitting its facility in Athlone, Ireland, aimed at expanding GLP-1 manufacturing capacity.
New contender enters oral weight loss drug race
The study suggests that the novel compound may offer superior glycaemic control and weight reduction compared with current GLP-1 drugs.
UK pharma M&A stalled, biotech thrived in 2025
A new report suggests biotech took the lead in UK healthcare M&A in 2025, outpacing pharma and life sciences.
AI and digital twins offer hope for rare disease research
Organisations like Phesi are leveraging digital patient profiles to create digital twins for even the rarest diseases.
EU targets 11% clinical trial growth to reclaim R&D lead
Meeting new EU targets for clinical trials could grant 35,000 additional patients access to novel treatments according to a new report.
Loading posts...
« Previous
1
…
7
8
9
10
11
…
52
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View